Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,562 | 98 | 97.6% |
| Education | $89.00 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Axonics, Inc. | $969.57 | 19 | $0 (2024) |
| Boston Scientific Corporation | $366.89 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $325.90 | 10 | $0 (2024) |
| PFIZER INC. | $183.78 | 5 | $0 (2024) |
| Coloplast Corp | $131.66 | 1 | $0 (2018) |
| NeoTract Inc. | $131.48 | 2 | $0 (2017) |
| Sumitomo Pharma America, Inc. | $122.82 | 6 | $0 (2024) |
| INTUITIVE SURGICAL, INC. | $121.18 | 3 | $0 (2024) |
| ABBVIE INC. | $120.70 | 5 | $0 (2024) |
| Blue Earth Diagnostics Limited | $114.70 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $856.34 | 31 | Axonics, Inc. ($139.97) |
| 2023 | $928.64 | 25 | Axonics, Inc. ($535.55) |
| 2022 | $261.85 | 9 | Axonics, Inc. ($85.32) |
| 2021 | $455.40 | 11 | Axonics, Inc. ($208.73) |
| 2020 | $160.91 | 2 | Boston Scientific Corporation ($125.71) |
| 2019 | $339.64 | 8 | Boston Scientific Corporation ($120.54) |
| 2018 | $279.49 | 3 | Coloplast Corp ($131.66) |
| 2017 | $369.03 | 10 | NeoTract Inc. ($131.48) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Urology | ||||||
| 11/06/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: UROLOGY | ||||||
| 09/03/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Oncology | ||||||
| 07/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/09/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: ONCOLOGY | ||||||
| 07/09/2024 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: Urology | ||||||
| 07/03/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $21.97 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 07/01/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $15.37 | General |
| 06/25/2024 | C. R. Bard, Inc. & Subsidiaries | Bard Urinary Drainage Bag (Device) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Urology | ||||||
| 06/17/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: ONCOLOGY | ||||||
| 06/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Oncology | ||||||
| 05/29/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: UROLOGY | ||||||
| 05/28/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $41.95 | General |
| Category: SURGERY | ||||||
| 05/22/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 05/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: UROLOGY | ||||||
| 04/09/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $25.59 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 03/27/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: UROLOGY | ||||||
| 03/21/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $105.46 | General |
| Category: LithoVue_URO | ||||||
| 03/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: UROLOGY | ||||||
| 03/21/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: LithoVue_URO | ||||||
| 03/06/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 294 | 345 | $94,949 | $22,890 |
| 2022 | 6 | 175 | 198 | $47,279 | $11,448 |
| 2021 | 7 | 221 | 247 | $54,132 | $15,293 |
| 2020 | 3 | 64 | 71 | $15,907 | $4,630 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 67 | 89 | $25,051 | $6,000 | 24.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 59 | 77 | $17,394 | $4,242 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 42 | 42 | $16,074 | $3,901 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 41 | 50 | $9,538 | $2,296 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 18 | 18 | $7,573 | $1,675 | 22.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 14 | 14 | $6,599 | $1,483 | 22.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 15 | 15 | $5,478 | $1,438 | 26.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $4,562 | $1,172 | 25.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 14 | 15 | $1,361 | $366.60 | 26.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2023 | 12 | 13 | $1,320 | $315.12 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 35 | 42 | $11,256 | $3,065 | 27.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 50 | 58 | $13,433 | $3,004 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 32 | 32 | $11,812 | $2,869 | 24.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 29 | 34 | $6,143 | $1,272 | 20.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 16 | 18 | $3,273 | $912.44 | 27.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Facility | 2022 | 13 | 14 | $1,362 | $325.24 | 23.9% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 57 | 66 | $14,583 | $3,743 | 25.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 38 | 44 | $10,846 | $3,298 | 30.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 34 | 34 | $11,581 | $3,263 | 28.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 43 | 53 | $8,668 | $2,580 | 29.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 21 | 21 | $4,809 | $1,284 | 26.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 17 | 18 | $2,505 | $937.44 | 37.4% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Facility | 2021 | 11 | 11 | $1,141 | $187.20 | 16.4% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2020 | 25 | 29 | $6,590 | $1,853 | 28.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 18 | 18 | $5,833 | $1,816 | 31.1% |
About Dr. Christopher Foote, D.O
Dr. Christopher Foote, D.O is a Urology healthcare provider based in Lewiston, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1912310442.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Foote, D.O has received a total of $3,651 in payments from pharmaceutical and medical device companies, with $856.34 received in 2024. These payments were reported across 99 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($3,562).
As a Medicare-enrolled provider, Foote has provided services to 754 Medicare beneficiaries, totaling 861 services with total Medicare billing of $54,260. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Student in an Organized Health Care Education/Training Program, Urology
- Location Lewiston, ME
- Active Since 06/02/2014
- Last Updated 08/02/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1912310442
Products in Payments
- Axonics (Device) $609.33
- Bulkamid (Device) $324.57
- XTANDI (Drug) $321.31
- GEMTESA (Drug) $144.22
- BOTOX (Biological) $137.22
- XIAFLEX (Biological) $133.47
- SUPRIS (Device) $131.66
- Urolift - UL400 (Device) $131.48
- REZUM (Device) $125.71
- Da Vinci Surgical System (Device) $121.18
- LithoVue (Device) $120.64
- Axumin (Drug) $114.70
- Myrbetriq (Drug) $111.41
- iTIND System (Device) $109.53
- GENERAL (Device) $103.04
- JATENZO (Drug) $78.05
- Xtandi (Drug) $76.96
- INTERSTIM (Device) $63.00
- ADSTILADRIN (Biological) $58.96
- Bard Urinary Drainage Bag (Device) $54.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Lewiston
Dr. Evan Dunn, M.d, M.D
Urology — Payments: $9,011
Dr. Christopher Henry, Md, MD
Urology — Payments: $7,213
Michael Parker, Md, MD
Urology — Payments: $4,383
Dr. Jordan Kurta, Md, MD
Urology — Payments: $2,129
Paul Mailhot, Md, MD
Urology — Payments: $59.33
David Pakula, Md, MD
Urology